Novuson has developed what we believe is the next generation of electrosurgical devices that are safer and more effective than current electrosurgical devices. We plan for our Direct Therapeutic Ultrasound surgical devices to disrupt the surgical device market, improving patient safety. Novuson is pre-revenue and in the prototype phase - - (Novuson has four prototype products (of which our 3mm Mini LS is close to regulatory clearance) and an energy console.)
Novuson plans to grow with nimble product development efforts. We hope to launch a new product every six to nine months and currently have three additional prototypes ready for design for manufacturing. Interest from major electrosurgical device manufacturers to integrate Novusons technology could further diversify our market presence. The current technologies that seal and divide tissue do not prioritize the safety of patients and the success of surgeons. Its time to finally cut through the limitations and risks with innovation.